NCT02313792View on ClinicalTrials.gov

Palifermin for Patients Receiving Hematopoietic Stem Cell Transplantation

PHASE3UnknownINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

March 31, 2015

Study Completion Date

June 30, 2015

Conditions
Mucositis
Interventions
DRUG

Palifermin

Sponsors

Collaborators (1)

BLNH
All Listed Sponsors
collaborator

BLNH

UNKNOWN

lead

The Catholic University of Korea

OTHER

NCT02313792 - Palifermin for Patients Receiving Hematopoietic Stem Cell Transplantation | Biotech Hunter | Biotech Hunter